These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24645843)

  • 1. Renal tumor-derived exosomes inhibit hepaCAM expression of renal carcinoma cells in a p-AKT-dependent manner.
    Jiang XL; Zhang Y; Tan B; Luo CL; Wu XH
    Neoplasma; 2014; 61(4):416-23. PubMed ID: 24645843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HepaCAM induces G1 phase arrest and promotes c-Myc degradation in human renal cell carcinoma.
    Zhang QL; Luo CL; Wu XH; Wang CY; Xu X; Zhang YY; Liu Q; Shen SL
    J Cell Biochem; 2011 Oct; 112(10):2910-9. PubMed ID: 21618595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of renal carcinoma cell line ACHN-derived exosomes on ACHN cell proliferation and apoptosis].
    Yang L; Wu X; Luo C; He Y; Zhang Y; Chen X; Zhang L; Chen L
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Oct; 32(10):1498-502. PubMed ID: 23076194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of hepaCAM and its effect on proliferation of tumor cells in renal cell carcinoma.
    Xun C; Luo C; Wu X; Zhang Q; Yan L; Shen S
    Urology; 2010 Apr; 75(4):828-34. PubMed ID: 20110109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 786-0 renal cancer cell-derived exosomes promote angiogenesis by downregulating the expression of hepatocyte cell adhesion molecule.
    Zhang L; Wu X; Luo C; Chen X; Yang L; Tao J; Shi J
    Mol Med Rep; 2013 Jul; 8(1):272-6. PubMed ID: 23652371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. let-7b and let-7c are determinants of intrinsic chemoresistance in renal cell carcinoma.
    Peng J; Mo R; Ma J; Fan J
    World J Surg Oncol; 2015 May; 13():175. PubMed ID: 25951903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased expression of NPRL2 in renal cancer cells is associated with unfavourable pathological, proliferation and apoptotic features.
    Tang Y; Jiang L; Tang W
    Pathol Oncol Res; 2014 Oct; 20(4):829-37. PubMed ID: 24789683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transcription factor PAX2 regulates ADAM10 expression in renal cell carcinoma.
    Doberstein K; Pfeilschifter J; Gutwein P
    Carcinogenesis; 2011 Nov; 32(11):1713-23. PubMed ID: 21880579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of SIPL1 screened by suppression subtractive hybridization (SSH) on biological function and drug resistance of renal cell carcinoma cells].
    Li CY; Yao AM; Chang XN; Guo YH; Xu R
    Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):897-903. PubMed ID: 24506958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polo-like kinase 1 is overexpressed in renal cancer and participates in the proliferation and invasion of renal cancer cells.
    Zhang G; Zhang Z; Liu Z
    Tumour Biol; 2013 Jun; 34(3):1887-94. PubMed ID: 23494182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. hepaCAM and p-mTOR closely correlate in bladder transitional cell carcinoma and hepaCAM expression inhibits proliferation via an AMPK/mTOR dependent pathway in human bladder cancer cells.
    Wang Q; Luo C; Wu X; Du H; Song X; Fan Y
    J Urol; 2013 Nov; 190(5):1912-8. PubMed ID: 23669565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High TXNDC5 expression predicts poor prognosis in renal cell carcinoma.
    Mo R; Peng J; Xiao J; Ma J; Li W; Wang J; Ruan Y; Ma S; Hong Y; Wang C; Gao K; Fan J
    Tumour Biol; 2016 Jul; 37(7):9797-806. PubMed ID: 26810069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of proline-rich tyrosine kinase 2 is associated with poor survival of hepatocellular carcinoma via regulating phosphatidylinositol 3-kinase/AKT pathway.
    Cao J; Chen Y; Fu J; Qian YW; Ren YB; Su B; Luo T; Dai RY; Huang L; Yan JJ; Wu MC; Yan YQ; Wang HY
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S312-23. PubMed ID: 22618716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-203a regulates proliferation, migration, and apoptosis by targeting glycogen synthase kinase-3β in human renal cell carcinoma.
    Hu G; Lai P; Liu M; Xu L; Guo Z; Liu H; Li W; Wang G; Yao X; Zheng J; Xu Y
    Tumour Biol; 2014 Nov; 35(11):11443-53. PubMed ID: 25123268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. hZIP1 that is down-regulated in clear cell renal cell carcinoma is negatively associated with the malignant potential of the tumor.
    Dong X; Kong C; Zhang Z; Liu X; Zhan B; Chen Z; Shi D
    Urol Oncol; 2014 Aug; 32(6):885-92. PubMed ID: 24878177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylenetetrahydrofolate Dehydrogenase 1 (MTHFD1) is Underexpressed in Clear Cell Renal Cell Carcinoma Tissue and Transfection and Overexpression in Caki-1 Cells Inhibits Cell Proliferation and Increases Apoptosis.
    He D; Yu Z; Liu S; Dai H; Xu Q; Li F
    Med Sci Monit; 2018 Nov; 24():8391-8400. PubMed ID: 30459299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PLAGL1 (ZAC1/LOT1) Expression in Clear Cell Renal Cell Carcinoma: Correlations with Disease Progression and Unfavorable Prognosis.
    Godlewski J; Krazinski BE; Kowalczyk AE; Kiewisz J; Kiezun J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Maslowski Z; Kmiec Z
    Anticancer Res; 2016 Feb; 36(2):617-24. PubMed ID: 26851016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM29 promotes progression of thyroid carcinoma via activating P13K/AKT signaling pathway.
    Xu J; Li Z; Su Q; Zhao J; Ma J
    Oncol Rep; 2017 Mar; 37(3):1555-1564. PubMed ID: 28098872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt antagonist DICKKOPF-3 (Dkk-3) induces apoptosis in human renal cell carcinoma.
    Ueno K; Hirata H; Majid S; Chen Y; Zaman MS; Tabatabai ZL; Hinoda Y; Dahiya R
    Mol Carcinog; 2011 Jun; 50(6):449-57. PubMed ID: 21268126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma.
    Zhou JD; Shen F; Ji JS; Zheng K; Huang M; Wu JC
    Oncol Rep; 2013 Sep; 30(3):1275-84. PubMed ID: 23836295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.